Head and neck cancer tumors dramatically alter one-carbon metabolism—the chemical process cells use to make new DNA and control growth—with the strongest changes occurring in the tumor’s center where oxygen is scarce, according to Gram Research analysis of tissue samples. Researchers found elevated levels of S-adenosylmethionine and related molecules that fuel cancer cell growth, suggesting these metabolic changes could become targets for new cancer treatments.
Scientists studied how head and neck cancer changes the chemical makeup of tumor tissue compared to healthy tissue nearby. Using advanced lab techniques, researchers found that cancer cells dramatically alter how the body processes certain molecules, especially those involved in making new cells and controlling growth. These changes were strongest in the center of tumors where oxygen is scarce. The findings could help doctors better understand how cancer grows and potentially develop new treatments that target these specific chemical changes.
Key Statistics
A 2026 research article published in the British Journal of Cancer found that head and neck cancer tumors show widespread elevation of S-adenosylmethionine and related one-carbon metabolites, with the strongest changes in the tumor core where oxygen levels are lowest.
Markers of low oxygen including lactate, succinate, and fumarate were significantly elevated in both the tumor edge and core compared to adjacent healthy tissue, with stronger changes observed in the tumor core according to the 2026 metabolomics study.
The 2026 analysis identified specific metabolic correlations between histidine, tryptophan, choline, and one-carbon metabolism molecules that appeared only in tumor tissue, suggesting cancer cells fundamentally rewire how they process these nutrients.
The Quick Take
- What they studied: How the chemical composition of head and neck cancer tumors differs between the tumor’s center, its outer edge, and healthy tissue next to it.
- Who participated: Patient tissue samples from head and neck cancer cases, analyzed in three distinct regions: tumor core, tumor edge, and adjacent healthy tissue.
- Key finding: According to Gram Research analysis, head and neck cancer tumors show widespread changes in one-carbon metabolism—the process cells use to make new DNA and control growth—with the strongest changes occurring in the tumor’s center where oxygen levels are lowest.
- What it means for you: These findings could help researchers develop new cancer treatments that target the specific chemical changes cancer cells make. However, this is laboratory research and doesn’t yet translate to new treatments for patients.
The Research Details
Researchers collected tissue samples from patients with head and neck cancer and divided each sample into three regions: the tumor’s core (center), the tumor’s edge (outer boundary), and healthy tissue adjacent to the tumor. They used a sophisticated laboratory technique called ultra-high performance liquid chromatography-mass spectrometry, which is like a super-sensitive chemical detector that can identify thousands of different molecules in tissue samples.
Once they identified all the chemicals present, they compared which molecules were present in different amounts across the three tissue regions. They looked for patterns and connections between different chemicals to understand how the cancer was changing the body’s metabolism—essentially how cells process and use different substances.
This regional approach is important because tumors aren’t uniform; the center often has less oxygen than the edges, which could affect how cancer cells function differently in different parts of the tumor.
Understanding how cancer changes metabolism is crucial because these chemical changes are what allow cancer cells to grow faster and survive better than normal cells. By mapping out exactly which chemicals change and where, scientists can identify potential targets for new drugs. This approach also reveals that cancer doesn’t affect all parts of a tumor equally, which could explain why some cancer treatments work better than others.
This study used advanced, well-established laboratory techniques published in a respected cancer research journal. The researchers performed multiple types of statistical analysis to ensure their findings were reliable. However, the study doesn’t specify the exact number of patient samples analyzed, which would help readers assess how broadly these findings might apply. The work is exploratory research designed to identify patterns rather than prove that a specific treatment works.
What the Results Show
The research revealed that head and neck cancer tumors show dramatic changes in how cells process molecules related to growth and cell division. Specifically, the tumors accumulated higher levels of S-adenosylmethionine (SAM), a crucial molecule that cells use to make new DNA and control which genes are turned on or off. This SAM buildup was particularly pronounced in the tumor’s core.
The study also found that markers of low oxygen—lactate, succinate, and fumarate—were elevated in both the tumor’s edge and core compared to healthy tissue, with stronger changes in the core. This makes sense because tumor centers typically have poor blood supply and less oxygen.
Interestingly, several amino acids (the building blocks of proteins) showed unusual patterns in tumor tissue. Histidine, tryptophan, and choline were all elevated in tumor tissue, and these appeared to be connected to the SAM metabolism changes. The researchers found specific correlations between these molecules only in tumor tissue, suggesting cancer cells are rewiring how they use these nutrients.
The study identified several metabolites (chemical byproducts) that were altered in cancer tissue, including polyamines, methylated nucleosides, and dimethylarginine. These are all involved in cell growth and division. The tumor edge and core showed different patterns of these changes, with the core showing more dramatic alterations. This suggests that the tumor’s internal environment—particularly low oxygen levels—drives these metabolic changes.
These findings align with existing cancer research showing that tumors dramatically alter their metabolism to support rapid growth. Previous studies have shown that cancer cells often shift their metabolism to rely less on oxygen, which matches this study’s findings of elevated hypoxia markers. The specific focus on one-carbon metabolism and SAM is relatively novel for head and neck cancer, adding new detail to our understanding of how this particular cancer type operates.
The study doesn’t specify how many patient samples were analyzed, making it difficult to assess how representative these findings are. This is exploratory research identifying patterns rather than proving cause-and-effect relationships. The findings are from laboratory analysis of tissue samples and don’t yet show whether targeting these metabolic changes would actually help patients. Additionally, the study doesn’t compare results across different types of head and neck cancer or different stages of disease, so it’s unclear if these patterns apply equally to all patients.
The Bottom Line
This research is preliminary and doesn’t yet support specific patient recommendations. However, it provides a foundation for future research into new cancer treatments that target one-carbon metabolism. Patients with head and neck cancer should continue following their oncologist’s current treatment recommendations while researchers explore whether these metabolic insights lead to new therapies.
Oncologists and cancer researchers should pay attention to these findings as they develop new treatment strategies. Patients with head and neck cancer may eventually benefit if these insights lead to new drugs, but that’s likely years away. This research is most relevant to the scientific community right now.
This is basic research, not a clinical treatment study. It typically takes 10-15 years for laboratory discoveries to become available treatments for patients. The next steps would be testing whether drugs targeting these metabolic changes actually slow cancer growth in laboratory and animal studies.
Frequently Asked Questions
What is one-carbon metabolism and why does cancer change it?
One-carbon metabolism is how cells make new DNA and control which genes turn on or off. Cancer cells boost this process dramatically to support rapid growth and division. The 2026 study found head and neck tumors accumulate S-adenosylmethionine, a key one-carbon molecule, especially in the tumor’s center.
Does this research mean there’s a new treatment for head and neck cancer?
Not yet. This is exploratory research identifying how cancer changes metabolism. Scientists must now test whether drugs targeting these metabolic changes actually slow cancer growth. New treatments typically take 10-15 years to develop from laboratory discoveries.
Should cancer patients change their diet based on these findings?
Not based on this study alone. While the research identifies nutrients connected to cancer metabolism (folate, choline, amino acids), it doesn’t prove dietary changes help patients. Discuss any dietary changes with your oncology team before making them.
Why is the tumor’s center different from its edges?
Tumor centers have poor blood supply and low oxygen, creating a harsh environment. The 2026 study found this low-oxygen environment drives stronger metabolic changes in the core, including higher levels of molecules that help cancer cells survive without oxygen.
How could this research lead to better cancer treatments?
By identifying specific metabolic changes in cancer cells, researchers can design drugs to block these processes. The study’s findings about one-carbon metabolism and S-adenosylmethionine could become targets for new therapies that starve cancer cells of the molecules they need to grow.
Want to Apply This Research?
- For cancer patients: Track nutritional intake of folate, choline, and amino acids (histidine, tryptophan) as these appear metabolically connected to tumor growth. Log daily intake amounts and any changes in energy levels or symptoms.
- While this research doesn’t yet support specific dietary changes for cancer patients, it suggests that certain nutrients may be important in cancer metabolism. Patients could work with their oncology team to ensure adequate but not excessive intake of the nutrients identified in this study.
- Long-term tracking should focus on monitoring how nutritional status correlates with cancer progression markers during treatment, in consultation with the patient’s medical team. This data could help personalize nutrition support as new treatments targeting these metabolic pathways are developed.
This research is exploratory laboratory science and does not yet support specific clinical recommendations or dietary changes for cancer patients. Head and neck cancer patients should continue following their oncologist’s treatment plan and discuss any dietary or supplement changes with their medical team before implementing them. These findings may eventually lead to new treatments, but that process typically takes many years. This article is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.